1. Home
  2. GALT vs CNXN Comparison

GALT vs CNXN Comparison

Compare GALT & CNXN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GALT
  • CNXN
  • Stock Information
  • Founded
  • GALT 2000
  • CNXN 1982
  • Country
  • GALT United States
  • CNXN United States
  • Employees
  • GALT N/A
  • CNXN N/A
  • Industry
  • GALT Biotechnology: Pharmaceutical Preparations
  • CNXN Catalog/Specialty Distribution
  • Sector
  • GALT Health Care
  • CNXN Consumer Discretionary
  • Exchange
  • GALT Nasdaq
  • CNXN Nasdaq
  • Market Cap
  • GALT 232.3M
  • CNXN 1.6B
  • IPO Year
  • GALT N/A
  • CNXN 1998
  • Fundamental
  • Price
  • GALT $4.59
  • CNXN $62.85
  • Analyst Decision
  • GALT Strong Buy
  • CNXN
  • Analyst Count
  • GALT 3
  • CNXN 0
  • Target Price
  • GALT $6.00
  • CNXN N/A
  • AVG Volume (30 Days)
  • GALT 348.2K
  • CNXN 87.5K
  • Earning Date
  • GALT 11-12-2025
  • CNXN 10-29-2025
  • Dividend Yield
  • GALT N/A
  • CNXN 0.95%
  • EPS Growth
  • GALT N/A
  • CNXN N/A
  • EPS
  • GALT N/A
  • CNXN 3.29
  • Revenue
  • GALT N/A
  • CNXN $2,894,353,000.00
  • Revenue This Year
  • GALT N/A
  • CNXN $7.92
  • Revenue Next Year
  • GALT N/A
  • CNXN $5.82
  • P/E Ratio
  • GALT N/A
  • CNXN $19.15
  • Revenue Growth
  • GALT N/A
  • CNXN 4.94
  • 52 Week Low
  • GALT $0.73
  • CNXN $56.72
  • 52 Week High
  • GALT $6.55
  • CNXN $77.19
  • Technical
  • Relative Strength Index (RSI)
  • GALT 53.65
  • CNXN 46.00
  • Support Level
  • GALT $4.21
  • CNXN $62.24
  • Resistance Level
  • GALT $6.55
  • CNXN $65.36
  • Average True Range (ATR)
  • GALT 0.47
  • CNXN 1.55
  • MACD
  • GALT -0.05
  • CNXN -0.16
  • Stochastic Oscillator
  • GALT 24.03
  • CNXN 12.50

About GALT Galectin Therapeutics Inc.

Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.

About CNXN PC Connection Inc.

PC Connection Inc is a provider of information technology solutions. It provides products such as computer systems, software and peripheral equipment, networking communications, and other products and accessories that company purchase from manufacturers and distributors. The company also offers services involving design, configuration, and implementation of IT solutions. It conducts business operations through three business segments namely Connection Business Solutions, Connection Enterprise Solutions, and Connection Public Sector Solutions. The company generates maximum revenue Connection Enterprise Solutions segment.

Share on Social Networks: